Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04083365
Title Capecitabine Plus Concomitant Radiation Therapy Followed by Durvalumab as Preoperative Treatment in Rectal Cancer (PANDORA)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AUSL Romagna Rimini
Indications

rectum adenocarcinoma

Therapies

Capecitabine + Durvalumab

Age Groups: senior | adult
Covered Countries


No variant requirements are available.